You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRBP Sale Disclosure
Cohen Yuval · SEC Form 4 · Filed Aug 10, 2026
Sale
Calculated transaction value
$171.4K
Cohen Yuval Chief Executive Officer
CRBP
Transaction date
Aug 7, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 3 days later
CRBP daily price context
Close on/before transaction
$10.17
Aug 7, 2026
First close after public filing
$9.51
Aug 11, 2026
30-day return after filing
-6.83%
Through Sep 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 17,000 shares @ $10.08
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-342485
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$171.4K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. CRBP Current | Sale | Aug 7, 2026 | $171.4K |